Clinical Trials Browser

Phase 2/3 × Melanoma × Imiquimod × Clear all

NCT01088737 2019-08-13

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Phase 2/3 Unknown

Melanoma, Hutchinson's Melanotic Freckle